Clinical Trials Browser

Phase 2/3 × Leukemia, Lymphocytic, Chronic, B-Cell × fludarabine × Clear all

NCT01423032 2011-08-25

Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL)

Phase 2/3 Completed

LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell